Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lin-Zhi International is a diagnostic company specializing in the development and manufacture of rapid, high-quality enzyme immunoassay (EIA) test kits for drugs of abuse testing and therapeutic drug monitoring. Founded in 1994 and headquartered in Santa Clara, California, the company provides a wide range of assays compatible with various automated clinical chemistry analyzers. Their product portfolio includes tests for traditional drugs such as opioids and stimulants, as well as specialized analytes like fentanyl, synthetic cannabinoids, and various prescription medications. Lin-Zhi International serves clinical laboratories, forensic toxicology labs, and workplace testing facilities globally, maintaining ISO 13485 certification for its manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lin-Zhi International.